IRIS
CONSOLARO, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.966
AS - Asia 2.045
NA - Nord America 1.760
Continente sconosciuto - Info sul continente non disponibili 575
SA - Sud America 155
AF - Africa 41
OC - Oceania 1
Totale 20.543
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.654
US - Stati Uniti d'America 1.626
SG - Singapore 804
CN - Cina 446
BD - Bangladesh 334
VN - Vietnam 265
FR - Francia 134
BR - Brasile 84
HK - Hong Kong 60
CA - Canada 59
DE - Germania 33
AR - Argentina 27
GB - Regno Unito 24
IN - India 22
FI - Finlandia 19
JP - Giappone 18
MX - Messico 17
NL - Olanda 16
IQ - Iraq 14
EC - Ecuador 13
ID - Indonesia 13
CO - Colombia 11
ES - Italia 11
JM - Giamaica 11
TR - Turchia 11
RU - Federazione Russa 10
VE - Venezuela 9
CR - Costa Rica 8
IE - Irlanda 8
MA - Marocco 8
SE - Svezia 8
CH - Svizzera 7
KE - Kenya 7
PK - Pakistan 7
ZA - Sudafrica 7
HN - Honduras 6
PH - Filippine 6
PR - Porto Rico 6
RO - Romania 6
SA - Arabia Saudita 6
DZ - Algeria 5
EG - Egitto 5
TN - Tunisia 5
AT - Austria 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
NI - Nicaragua 4
PL - Polonia 4
PY - Paraguay 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UA - Ucraina 4
BE - Belgio 3
BO - Bolivia 3
BY - Bielorussia 3
CL - Cile 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
RS - Serbia 3
SV - El Salvador 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BZ - Belize 2
CZ - Repubblica Ceca 2
KH - Cambogia 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
SI - Slovenia 1
SN - Senegal 1
TG - Togo 1
TZ - Tanzania 1
Totale 19.967
Salva come PNG Salva come JPEG
Città #
Genova 8.887
Genoa 3.805
Rapallo 1.366
Vado Ligure 1.299
Singapore 391
San Jose 356
Ashburn 212
Council Bluffs 132
Lauterbourg 115
Beijing 90
New York 90
Ho Chi Minh City 80
Hanoi 65
Hong Kong 58
Santa Clara 45
Los Angeles 44
Bordighera 31
Buffalo 27
Frankfurt am Main 27
Milan 23
Naples 20
Chicago 19
Boardman 17
Rome 17
Tokyo 17
Dallas 16
Haiphong 16
Toronto 15
Orem 14
Da Nang 11
Mexico City 11
Bologna 10
Helsinki 10
Montreal 10
Denver 9
Phoenix 9
Amsterdam 8
Atlanta 8
Chennai 8
Lappeenranta 8
Philadelphia 8
Princeton 8
Washington 8
Cardiff 7
Charlotte 7
Kingston 7
Queens 7
Shanghai 7
Alessandria 6
Brooklyn 6
City of London 6
Dublin 6
Las Vegas 6
Montoro 6
Palermo 6
Paris 6
Piscataway 6
Seattle 6
São Paulo 6
Tianjin 6
Biên Hòa 5
Hải Dương 5
Miami 5
Orlando 5
San José 5
Zurich 5
Acalanes Ridge 4
Baghdad 4
Boston 4
Florence 4
Guatemala City 4
Hillsboro 4
Houston 4
Istanbul 4
Kyiv 4
La Spezia 4
London 4
L’Aquila 4
Managua 4
Manchester 4
Manlius 4
Medellín 4
Medford 4
Memphis 4
Nairobi 4
Portland 4
Reggio Emilia 4
Richmond 4
Rio de Janeiro 4
San Francisco 4
Tucson 4
Turin 4
Warsaw 4
Agadir 3
Amman 3
Belgrade 3
Cairo 3
Calgary 3
Cape Town 3
Caracas 3
Totale 17.686
Salva come PNG Salva come JPEG
Nome #
Juvenile Idiopathic Arthritis: Diagnosis and Treatment 220
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis 216
The Slovene version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 207
Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score 206
Development and validation of a composite disease activity score for juvenile idiopathic arthritis 205
Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology 202
Parent and child acceptable symptom state in juvenile idiopathic arthritis. 201
MRI versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in juvenile idiopathic arthritis. 201
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis 201
The Croatian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 199
Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis 193
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 191
Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial 190
IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis 186
Advances in biomarkers for paediatric rheumatic diseases 183
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 182
Clinical outcome measures in juvenile idiopathic arthritis 181
Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016 181
The Slovak version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 179
A New Approach to Clinical Care of Juvenile Idiopathic Arthritis: The Juvenile Arthritis Multidimensional Assessment Report 177
Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis 174
Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases 173
Development and testing of a hybrid measure of muscle strength in juvenile dermatomyositis for use in routine care 172
The Canadian English and French versions of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 172
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis 168
An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis 166
Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis 165
Disease activity and damage in juvenile idiopathic arthritis: Methotrexate era versus biologic era 165
Development and initial validation of composite parent and child centered disease assessment indices for juvenile idiopathic arthritis. 165
Evaluation of 21-Numbered Circle and 10-Centimeter Horizontal Line Visual Analog Scales for Physician and Parent Subjective Ratings in Juvenile Idiopathic Arthritis 164
A child with a novel ACAN missense variant mimicking a septic arthritis 163
Factors associated with achievement of inactive disease in children with juvenile idiopathic arthritis treated with etanercept. 160
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study 160
Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study. 159
Recent therapeutic advances in juvenile idiopathic arthritis 159
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries 158
Filling the Gap: Toward a Disease Activity Tool for Systemic Juvenile Idiopathic Arthritis 156
The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 156
The Algerian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 156
The Bulgarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 154
Defining criteria for disease activity States in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. 152
Development and testing of reduced joint counts in juvenile idiopathic arthritis. 150
The Chilean Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 150
Predictors of effectiveness of anakinra in systemic juvenile idiopathic arthritis 150
The Swedish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 149
The Omani Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 149
Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop 148
The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 147
The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 147
The Colombian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 146
The Russian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 146
The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 145
The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 145
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. 144
The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 144
The Afrikaans version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 144
TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis 143
The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 142
The Latvian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 142
The Castilian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 142
The Hindi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 141
The Lithuanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 141
Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI). 140
Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era. 139
Unraveling the phenotypic variability of juvenile idiopathic arthritis across races or geographic areas - Key to understanding etiology and genetic factors? 139
The Swiss French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 139
The Estonian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 139
The Mexican Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 138
The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 138
Prevalence of overweight and obesity in 2- to 6-year-old Italian children 137
The Ukrainian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 137
Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score. 137
The Thai version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 137
The Hebrew version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 136
The Czech version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 136
Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis. 135
The Argentinian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 135
The Farsi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 135
Determinants of discordance between criteria for inactive disease and low disease activity in juvenile idiopathic arhritis 135
It is worth including assessment of disease activity state in juvenile arthritis clinical trials. 134
The Danish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 134
The Georgian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 134
The Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 134
Defining criteria for disease activity states in juvenile idiopathic arthritis 132
Glucocorticoids in juvenile idiopathic arthritis. 131
The Paraguayan Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 131
Critical role of STIR MRI in early detection of post-streptococcal periostitis with dysproteinaemia (Goldbloom's syndrome) 129
The Brazilian Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 129
The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 129
Paediatric rheumatology: Juvenile idiopathic arthritis--are biologic agents effective for pain? 128
The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 128
Ghrelin, insulin sensitivity and postprandial glucose disposal in overweight and obese children 127
The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 127
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis 127
The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 125
The Libyan Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 125
Information technology in paediatric rheumatology 124
The Polish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 124
Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis. 123
Open issues in the assessment and management of pain in juvenile idiopathic arthritis 123
Totale 15.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.719
article - articoli 69.719
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.488 72 59 122 119 55 123 61 326 125 175 63 188
2022/20231.632 147 147 21 144 251 274 9 159 276 14 165 25
2023/2024822 35 113 35 110 71 73 89 46 41 35 48 126
2024/20252.973 78 217 111 208 422 365 297 469 75 139 240 352
2025/20265.284 577 161 216 233 667 468 720 217 392 572 491 570
2026/2027475 475 0 0 0 0 0 0 0 0 0 0 0
Totale 20.543